TherapeutAix is speaking at the 18th Fraunhofer Seminar “Models of Lung Disease”
Darcey Black, Translational Director of TherapeutAix, will be speaking at the 18th Fraunhofer Seminar titled “Models of Lung Disease” on Friday 25th of January. Held in Hannover, Germany, the two-day event will bring together 120 academics and industry experts for discussions on predictive disease models and translational lung research. Darcey will give a presentation entitled […]
2018 Round Up – It’s a wrap
Since 2018 is quickly coming to an end, we look back at the past few months and reflect on all that we have achieved. The launch of the business is all wrapped up and now we look forward to what 2019 will bring. We would like to thank all of our clients and contacts for […]
Navigating the NASH Maze
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis research and in the search for new anti-fibrotic agents. Nowhere is this more evident than in the field of non-alcoholic steatohepatitis (NASH). While there have been multiple review articles covering NASH of late, TherapeutAix is […]
TherapeutAix to present at ELRIG’s flagship conference, Drug Discovery
The European Laboratory Research & Innovation Group’s (ELRIG) flagship conference, Drug Discovery, is one of the largest meetings of life sciences industry professionals in the UK. Now in its 12th year, Drug Discovery 2018 will take place in London’s Excel Arena. The 2-day event will bring together more than 1200 delegates and over 100 exhibiting […]
TherapeutAix present at The Society for Medicines Research meeting
The Society for Medicines Research (SMR) is holding a meeting on 26th September 2018 in Stevenage titled, ‘The Best of Both Worlds: Innovation, Collaboration and Synergy between CROs and their Client Partners.’ The meeting will showcase innovation in science that has emerged from successful Client-CRO partnerships which have moved beyond fee-for-service agreements, towards much broader […]
Four Pharma experts team up to launch new life sciences consultancy
Four colleagues, who previously worked together in the Innovative Medicines Unit (IMU) at Grünenthal, have combined their strategic and operational R & D expertise to launch a new life sciences consultancy, TherapeutAix, based in Aachen, Germany. Specialising in fibrotic disease, inflammation and orphan indications, but with a track record across multiple therapeutic areas, TherapeutAix combines […]